Neuralstem Press Release: FDA Approval to Commence Phase II Stem Cell Trial for Lou Gehrigs Disease | ALS | #ALS AWARENESS #LouGehrigsDisease #PARKINSONS | Scoop.it
Neuralstem Receives FDA Approval To Commence Phase II Stem Cell Trial In Amytrophic Lateral Sclerosis